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Chromosome-5p minus syndrome (5p-Sd, OMIM #123450) formerly known as Cri du
Chat syndrome results from the loss of genetic material at the distal region of the
short arm of chromosome 5. It is a neurodevelopmental disorder of genetic cause.
So far, about 400 patients have been reported worldwide. Individuals affected by
this syndrome have large phenotypic heterogeneity. However, a specific phenotype
has emerged including global developmental delay, microcephaly, delayed speech,
some dysmorphic features, and a characteristic and monochromatic high-pitch voice,
resembling a cat’s cry. We here describe a cohort of 70 patients with clinical features
of 5p- Sd characterized by means of deep phenotyping, SNP arrays, and other genetic
approaches. Individuals have a great clinical and molecular heterogeneity, which can be
partially explained by the existence of additional significant genomic rearrangements in
around 39% of cases. Thus, our data showed significant statistical differences between
subpopulations (simple 5p deletions versus 5p deletions plus additional rearrangements)
of the cohort. We also determined significant “functional” differences between male and
female individuals.
Keywords: 5p-minus syndrome, intellectual disabilities, Cri du chat, subtelomeric deletion, behavior problems
INTRODUCTION
The syndrome of 5p- (5p- Sd) is caused by partial deletion of the short arm of chromosome 5.
The size of the deletion is variable ranging from 500 kb or less to 45 Mb (Simmons et al., 1995;
Gu et al., 2013; Elmakky et al., 2014). This syndrome is a rare chromosomal disease, with an
incidence between 1 in 15,000 and 1 in 50,000 live births (Niebuhr, 1978; Higurashi et al., 1990;
Cerruti Mainardi, 2006). The prevalence is higher among females (66%) than males, but the reason
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is unclear. No differences in prevalence between races or
geographical areas have been found or related to prenatal events
or age of the parents. In Spain, it is estimated that there
are around 500–700 patients (Rodríguez-Caballero et al., 2012,
and unpublished data from patient’s Associations). It has been
suggested that the great phenotypic variability observed among
individuals with this syndrome is related to both the size and the
location of the deletion (between 5p15.3 and 5p15.2 bands), since
it is a chromosomal region with a large gene content (Nguyen
et al., 2015; Correa et al., 2019).
Ninety percent of cases are de novo, and 10% are inherited,
due to a rearrangement in the parents (unbalanced segregation
of translocations, or recombination involving a pericentric
inversion, rarely a parental mosaicism, or an inherited terminal
deletion). In de novo cases, between 80% and 90% are of
paternal origin possibly due to chromosome breakage during
the formation of male gametes (Cerruti Mainardi et al., 2001).
Prenatal diagnoses in 5p- Sd (at 12–16 weeks of gestation) are
common because fetuses frequently show abnormal ultrasound
signs (∼65–90%) including cerebral abnormalities, cerebellar
hypoplasia, absent/hypoplastic nasal bone, hydrops fetalis,
ascites or encephalocele, hypospadias, lung dysplasia, IUGR,
microcephaly, and micro/retrognatia (Mak et al., 2019; Su et al.,
2019; Peng et al., 2020).
Over the past decade, the accuracy of genetic diagnosis
and the advances of analytical techniques have allowed to
expand the genetic information associated with the short arm of
chromosome 5. However, a full map of the involved genes in this
syndrome is not completely established, nor the consequences
of their haploisufficiency for subjects with 5p- Sd. In this sense,
Nguyen et al. (2015) established a role for 11 dose-sensitive
genes within the 5p- arm. In five of them, losses may lead to
haploinsufficiency (TERT, SEMA5A, MARCH6, CTNND2, and
NPR3), and in the remaining six genes their haploinsufficiency
is conditioned by an additional environmental factor (SLC6A3,
CDH18, CDH12, CDH10, CDH9, and CDH6). In addition, two
additional genes have been suggested to have haplolethal effects
(RICTOR and DAB2).
We here describe the clinical and molecular data of a
cohort of 70 unrelated patients with a cytogenetic and/or
molecular diagnosis of 5p- Sd. High-resolution single-nucleotide
polymorphism (SNP) array, cytogenetic, fluorescence in situ
hybridization (FISH), and multiplex ligation-probe amplification
(MLPA) techniques were applied to most patients, in order
to delineate the size, extent, gene content, and additional
rearrangements. Genotype–phenotype relationship analyses were
also established. A comparison of the clinical features with
published patients in the literature and relevant findings that all
patients share in this series were also discussed.
MATERIALS AND METHODS
Subjects
During the period between 2017 and 2020, around 100 patients
with 5p minus syndrome, formerly called Cri du chat syndrome
(CDCS), were recruited for this study in our center. At this
moment, around 30 cases had incomplete either clinical or
molecular data and were finally not included in this study. The
final cohort is constituted by 70 individuals (see Figure 1 and
Supplementary Data). Most of the DNA samples from these
patients were extracted and analyzed by SNP arrays at INGEMM
(Madrid, Spain), and standard cytogenetic studies were made
at the Spanish Collaborative Study of Congenital Malformations
Centre (ECEMC) and INGEMM. Clinical information of patients
was obtained from the referring physicians by two standardized
questionnaires (INGEMM and ECEMC), completed with data
of the medical reports, and interviewing most of the parents.
Parents or guardians provided informed consent and the




Cytogenetic analyses were performed on GTG-banded
metaphases at a resolution of about 550 bands according
to standard laboratory protocol using Chromosome Kit P
(Euroclone, Siziano PV, Italy). FISH was performed according
to standard laboratory protocols using commercial subtelomeric
5pter probes, LPU 013SA (covering CTNND2, 5p15.2 and
UBE2QL1, 5p15.31, with control at 5q35) and probe FLJ25076
(CytoCell Ltd., Tarrytown, NY, United States) and probe
CTNND2 (from Kreatech, Leica, Wetzlar, Germany).
Multiplex Ligation-Probe Amplification (MLPA)
We used MLPA Salsa kits P036 and P070 (subtelomeric probes
for all chromosomes) and/or P096 and P358 (specific telomeric
probes for the 5p arm) to characterize patients with 5p- Sd
(MRC Holland, Amsterdam, Netherland). Data analyses were
performed according to the protocols supplied by the provider
defining relative probe signals by dividing each measured peak
area by the sum of all peak areas of the control probes
of that sample. The ratio of each peak’s relative probe area
was then compared versus a DNA control sample (Promega,
United Kingdom), using Coffalyser v.9.4 (MRC Holland).
SNP-Array Analysis
A genome-wide scan of 850,000 tag SNPs (Infinium CytoSNP-
850k BeadChip, Illumina, San Diego, CA, United States) was
performed at INGEMM, in the majority of the patients, but three
(analyzed by array-CGH at ECEMC). They were analyzed by
using the Chromosome Viewer tool contained in the Genome
Studio package (Illumina). In Chromosome Viewer, gene call
scores <0.15 at any locus were considered “no calls.” In addition,
an allele frequency analysis was applied for all SNPs. All
genomic positions were established according to the 2009 human
genome build 19 (GRCh37/NCBI build 37.1). Deletion sizes were
plotted on the genome browser (Figure 2 and Supplementary
Data) using the University of California at Santa Cruz Genome
Browser1.
1http://genome.ucsc.edu/; Kent et al., 2002.
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FIGURE 1 | (A) Facial features of a patient with 5p minus syndrome at age of 6 days, 7 years, 11 years, and 21 years. (B) Details of different ear alterations.
(C) Details of several dental anomalies, and of a wide mouth. (D) Details of some hand and finger anomalies. (E) Details of several foot and toe anomalies.
FIGURE 2 | Schematic representation of very significant (P ≤ 0.01) inter-correlation among microcephaly and other categoric variables (Kendall’s tau_b analysis was
performed).
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TABLE 1 | Descriptive statistics for continuous variables in the whole cohort.
N Mean Standard deviation Median Range
Age at evaluation (years) 70 8.99 8.94 7.00 0.1–45
Gestational age at birth (weeks) 68 38.29 2.59 39.00 30–42
Weight at birth (g) 68 2,602.13 677.55 2,600.00 1,170–4,500
OFC at birth (cm) 68 32.20 2.42 32.00 27–37
Height at birth (cm) 68 45.89 3.90 46.75 32–52
Number of surgeries 70 0.71 1.37 0.0001 0–7
Size of deletion (Mb) 70 20.22 9.29 22.55 0.62–35.01
N, number of patients evaluated.
Validation of Global Functional Assessment of the
Patients (GFAP)
We estimated individual functional assessment in our cohort
by using different features taken from the questionnaires and
weighed them by Human Phenotype Ontology (HPO) term
frequencies in a numerical scale of five “nuclear” items in the
syndrome, based on our clinical experience. A final patient
assessment (GFAP) was constructed by the summatory of items
“(i) to (v)” as is indicated in Supplementary Table 1, and its
validation is explained in the “Results” section.
Statistical Analysis
Statistical analysis was performed with SPSS version 25 (IBM
Corporation, United States). Descriptive analysis included
mean ± SD for continuous variables and frequency tables for
categorical variables. These categorical variables were expressed
as 1 or 0, indeed grouped as “ever” having a given condition
compared to “never” having the condition, taken from the two
questionnaires and curated from medical records. Correlation
associations were calculated using Pearson’s linear correlation
coefficient (continuous variables) or Spearman’s Rho and
Kendall’s tau_b (categorical variables). Comparisons between two
groups (as based on sex or to have additional rearrangements)
were performed either by Student’s t-test (for continuous
variables) or by chi-square tests (for categorical ones). For more
than two groups, ANOVA analysis (and Bonferroni’s post hoc
tests) was run for continuous variables, and z-tests between
column proportions for categorical variables. PCA (principal
component analysis) was used to validate our GFAP construct,
containing Kaiser–Meyer–Olkin’s measure and Barlett’s test.
Ward’s minimum variance method was the criterion used in
hierarchical cluster analysis, and the number of clusters was
selected using the Bayesian information criterion (BIC) or Akaike
information criterion (AIC). A P-value (observed significance
level) lower than 0.05 or 0.01 was considered to indicate a
statistically significant or very significant difference, respectively.
RESULTS
Clinical Findings
We evaluate 70 unreported individuals. All but three were
from Spain (see Figure 1 and Supplementary Data). The
female/male ratio (2.04:1; 47/23) was very similar to previously
described cohorts, and ages ranged from birth to 45 years (see
Supplementary Table 2). The highest number of individuals with
5p- Sd in our cohort are individuals in the pediatric age (between
0 and 12 years, 77.23%). Descriptive statistics (for continuous
variables) and frequencies (for categoric items) are shown in
Tables 1, 2, respectively. The mean and median age at evaluation
were 8 years and 9 months, and 7 years old, respectively (Table 1).
Perinatal and Neonatal Data
Regarding neonatal data, the average gestational age of our cohort
was 38.28 ± 2.59 weeks (Table 1). Grossly, 53% (37 subjects)
were born between weeks 39th and 40th. Nineteen individuals
were born before the 38th week of gestation, three of them
below week 32th, and 27 after week 40th. The average birth
weight is 2602.13 ± 677.50 g (centile below 5%; Marinescu
et al., 2000), which corresponds to the average weight of a
neonate of 35th–36th weeks (at centile 50%), and the average
length, 45.89 ± 3.90 cm (centile below 5%; Marinescu et al.,
2000). Finally, the mean of the cephalic perimeter (OFC) at
birth was 32.20 ± 2.42 cm (centile below 5%; Marinescu et al.,
2000). More than one-third of subjects were hospitalized at birth.
The main causes were prematurity, low weight, and suspected
chromosomal abnormality. During the first months of life, several
individuals also had feeding difficulties.
Postnatal Clinical Findings
The frequencies of clinical features observed in this cohort
were recorded using the HPO terms and are listed in Table 3.
In Table 3, we also listed data from previous published
series of 5p- Sd individuals (Cerruti Mainardi et al., 2006;
Van Buggenhout et al., 2000; Rodríguez-Caballero et al., 2012;
Espirito Santo et al., 2016; Rodrigues de Medeiros, 2017;
Honjo et al., 2018; Chehimi et al., 2020). Figure 1A shows
that facial features are not always typical of the syndrome
and that a specific gestalt is not always present. Nonetheless,
microcephaly, large nose bridge, epicanthal folds, hypertelorism,
high arched palate, downturned corners of the mouth, round
face, ear anomalies (Figure 1B), dental alterations (Figure 1C),
short philtrum, micrognathia, and feeding difficulties were
present in around or higher than 60% of patients. These
should considered, in addition to hypotonia, typical cry/acute
voice, breathing problems, and behavior anomalies, as the
commonest features in this syndrome (Table 3). On the other
hand, alterations of the hands or feet (see Figures 1D,E),
hyperlaxity, divergent/convergent strabismus, down-slanting
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TABLE 2 | Frequencies for categorical variables in the whole cohort.
Categorical variables Female Male
Gender 47 (67.1%) 23 (32.9%)
0/“never”/condition not present 1/“ever”/condition present
IUGR 43 (61.4%) 27 (38.6%)
Postnatal growth failure 37 (52.9%) 33 (47.1%)
Microcephaly 11 (15.7%) 59 (84.3%)
Facial asymmetry 61 (87.1%) 99 (12.9%)
Round face 38 (54.3%) 32 (45.7%)
Enlarged face 47 (67.1%) 23 (32.9%)
Hearing problems 40 (57.1%) 30 (42.9%)
Ear alterations 32 (45.7%) 38 (54.3%)
Epicanthus 37 (52.9%) 33 (47.1%)
Ophtalmic anomalies 38 (54.3%) 32 (45.7%)
Prominent superciliary arches 65 (92.9%) 5 (7.1%)
Downslanted palpebral fissures 56 (80.0%) 14 (20.0%)
Hypertelorism 29 (41.4%) 41 (58.6%)
Palpebral fissures size anomalies 64 (91.4%) 6 (8.6%)
Nasal defects 56 (80.0%) 14 (20.0%)
Narrow nasal bridge 26 (37.1%) 44 (62.9%)
Short philtrum 60 (85.7%) 10 (14.3%)
Downturned corners of the mouth 62 (88.6%) 8 (11.4%)
Lip and palate anomalies 63 (90.0%) 7 (10.0%)
Micrognathia 40 (57.1%) 30 (42.9%)
Thick lower lip 54 (77.1%) 16 (22.9%)
Big mouth 52 (74.3%) 18 (25.7%)
Teeth alterations 36 (51.4%) 34 (48.6%)
Neck anomalies 57 (81.4%) 13 (18.6%)
Single palmar crease 58 (82.9%) 12 (17.1%)
Breath problems 43 (61.4%) 27 (38.6%)
Cardiac anomalies 46 (65.7%) 24 (34.3%)
Difficult to feed 42 (60.0%) 28 (40.0%)
Larynx and epiglottis alterations 47 (67.1%) 23 (32.9%)
Gastrointestinal anomalies 31 (44.3%) 39 (55.7%)
Renal anomalies 61 (87.1%) 9 (12.9%)
Genital anomalies 54 (77.1%) 16 (22.9%)
Anal anomalies 65 (92.9%) 5 (7.1%)
Limb anomalies 62 (88.6%) 8 (11.4%)
Alterations in hands or feet 39 (55.7%) 31 (44.3%)
Spinal anomalies 52 (74.3%) 18 (25.7%)
Scoliosis 45 (64.3%) 25 (35.7%)
Joint dislocation includes hip 55 (78.6%) 15 (21.4%)
Joint laxity 39 (55.7%) 31 (44.3%)
Pes cavus 57 (81.4%) 13 (18.6%)
MRI images 18 (25.7%) 52 (74.3%)
Anomalies in MRI images 32 (61.5%) 20 (38.5%)
Hypotonia 21 (30.0%) 49 (70.0%)
Hypertonia 63 (90.0%) 7 (10.0%)
Seizures 66 (94.3%) 4 (5.7%)
Developmental delay 4 (5.7%) 66 (94.3%)
Mild ID 62 (88.6%) 8 (11.4%)
Moderate ID 56 (80.0%) 14 (20.0%)
Severe ID 39 (55.7%) 31 (44.3%)
(Continued)
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TABLE 2 | Continued
Categorical variables Female Male
Behavior anomalies 50 (71.4%) 20 (28.6%)
Autism (ASD) 61 (87.1%) 9 (12.9%)
Hyperactivity 53 (75.7%) 17 (24.3%)
Aggressive and self-mutilation 43 (61.4%) 27 (38.6%)
Stereotypes and repetitive movements 39 (55.7%) 31 (44.3%)
Frustration intolerance 44 (62.9%) 26 (37.1%)
Uncontrolled laughs 50 (71.4%) 20 (28.6%)
Sleeping problems 32 (45.7%) 38 (54.3%)
Cephalic support 19 (27.1%) 51 (72.9%)
Able to stay seated 22 (31.4%) 48 (68.6%)
Able to stay seated unaided 24 (34.3%) 46 (65.7%)
Able to walk unaided 29 (41.4%) 41 (58.6%)
Able to walk with help 23 (32.9%) 47 (67.1%)
Use diapers 38 (55.7%) 31 (44.3%)
Interact with the environment 20 (28.6%) 50 (71.4%)
Can read/write 56 (83.4%) 12 (17.6%)
Use alternative communicative tools 39 (55.7%) 29 (41.4%)
No words at all 44 (65.7%) 26 (34.3%)
Use less than 10 words 43 (63.3%) 25 (36.7%)
Short understandable sentences 52 (76.5%) 16 (23.5%)
High-pitched or horsed cry 31 (44.3%) 39 (55.7%)
Cry w/o sound 68 (97.2%) 2 (2.8%)
Family member no longer work for care 38 (54.3%) 32 (45.7%)
Surgery 46 (67.1%) 24 (32.9%)
Suspicion of pathology prior to diagnosis 48 (68.6%) 22 (31.4%)
Normal electro encephalogram 54 (77.1%) 16 (22.9%)
Normal metabolic screening 53 (75.7%) 17 (24.3%)
Additional duplication 43 (61.4%) 27 (38.6%)
“1” means “ever” having a given condition compared to 0, “never” having the condition, taken from either of our two questionnaires, and curated from medical records.
palpebral fissures, stereotypies, gastrointestinal anomalies, short
neck, scoliosis, cardiac anomalies, and speech delay were present
in 25–59% of the cases and should be considered frequent
findings in the syndrome (Table 3).
It is remarkable that many of those called “nuclear clinical
features” (the most frequent findings) seemed to be interrelated
among them. Indeed, it showed significant positive correlation
among them when a Kendall’s tau_b analysis was performed.
For example, microcephaly presented in more than 65% of the
cases correlated with epicanthus, narrow nasal bridge, or ear
alterations. As an example, Figure 2 summarizes some of those
very significant intra-correlations (P ≤ 0.01), e.g., microcephaly.
The expandend analyses of these correlations are summarized in
Supplementary Table 3.
Brain MRI studies were performed in almost 75% of
the individuals, though only 28.6% showed some kind
of alterations (Table 2), including cerebellar amygdala
herniation, abnormalities of the corpus callosum (ranging
from thinness to agenesis), frontal horn ectasia, brainstem
hypoplasia, dilated ventricular system, cysts, or hydrocephalus.
Electroencephalograms showed normal results in only a reduced
number of individuals (12/70, 22.90%) (Table 2).
Speech abilities (evaluated only in patients aged ≥3 years;
n = 56) showed severe abnormalities in the majority of patients
(40/56; ∼71.50%). In fact, 30.35% of patients (17/56) had no
speech at all, 41.07% (23/56) had an elementary vocabulary of 10
words or less, and 28.57% (16/56) were reported to have a mild
vocabulary and the ability to use limited phrases for a short and
comprehensible conversation (Tables 2, 3).
As examples of comorbidities, almost 33% of the cohort
undertook at least one surgery (ranging from one to
seven, Table 1) and include ventricular septal defect (VSD),
percutaneous closure of the patent ductus arteriosus, closure of
open foramen oval, duodenal atresia, strabismus, and inguinal
hernia (the most frequent).
Genetic Findings
Breakpoint Data Analysis
SNP-array analysis was performed in most cases except three
patients who had comparative genomic hybridization (CGH
array). Genomic coordinates for microdeletions affecting the
short arm of chromosome 5 and other genomic rearrangements
are listed in Table 4. A graphic representation of the deletions
is shown in Supplementary Figure 2. Briefly, the average size
of the losses was 20.21 ± 9.28 Mb (range 0.62–35.01 Mb). SNP
arrays established the existence of other clinically significant
genomic rearrangements in almost 39% of the patients (Table 4);





















TABLE 3 | Phenotypic, comorbidities, and global developmental features of our cohort compared to previous published work.





















N N = 70 N = 220 N = 6 N = 73 N = 14 N = 7 N = 3 N = 32 432




2–38 years 17–23 years 2–35 years 0.1–45 years
Mean age 8.80 years 16.80 years 13.80 years 13.30 years 19.66 years 14.65 ± 10.19
years
12.32 years
Developmental delay (HP:0001263) 91.40 100.00 100.00 100.00 89.47 95.11
Hypotonia (HP:0003808) 70.00 72.20 100.00 100.00 87.50 99.38
Micrognathia (HP:0000347) 42.90 96.70 100.00 71.00 100.00 90.62 84.26
Epicanthal folds (HP:0000286) 47.10 90.20 83.30 85.71 100.00 93.75 81.67
Large nose bridge (HP:0000446) 62.90 87.20 100.00 57.00 71.42 100.00 93.75 81.78
Typical cry/acute voice (HP:0200046) 55.70 95.90 100.00 94.40 93.00 33.33 93.75 88.25
Hypertelorism (HP:0000316) 58.60 81.40 83.30 71.00 57.14 100.00 93.75 77.16
Aggressive and self- mutilation (HP:0000718) 84.60 65.63 78.65
Behavior anomalies (HP:0012433) 71.40 68.75 70.57
Round face (HP:0000311) 45.70 83.50 100.00 29.00 100.00 25.00 68.62
High arched palate (HP:0000218) 10.00 83.80 100.00 64.00 16/29 (56.17) 65.58
Independent walking 58.60 72.20 65.54
Low-set ears (HP:0000369) 54.30 69.80 33.30 14.28 100.00 78.12 65.20
Microcephaly (HP:0000252) 84.30 66.70 91.00 85.71 6.25 64.93
Use Diapers 44.30 84.00 64.56
Difficult to feed (HP:0011968) 40.00 60.00 80.30 71.87 62.55
Downturned corners of the mouth (HP:0002714) 11.40 81.00 64.20
Dental anomalies (HP:0000164) 48.60 75.00 100.00 13/23 (56.52) 58.30
Short philtrum (HP:0000322) 14.30 60.50 86.00 96.87 55.40
Hyperlaxity (HP:0002761) 44.30 78.12 54.91
Downslanting palpebrals fissures (HP:0200005) 20.00 56.90 83.30 48.71
Strabismus divergent/convergent (HP:0000486) 45.70 47.50 100.00 42.86 17/31 (54.83) 48.67
Short neck (HP:0000470) 18.60 56.20 33.30 100.00 47.38
Stereotypies (HP:0000733) (HP:0008762) 44.30 40.30 42.25
No words at all (HP:0001344) 35.30 47.20 41.37
Hyperactivity (HP:0000752) 24.30 71.87 39.22
Scoliosis (HP:0002944) 35.70 33.30 28.80 42.60 38.41
Breath problems (HP:0002098) 38.60 100.00 38.38
Cardiac anomalies (HP:0115080) 34.30 35.80 31.50 100.00 14/29 (48.27) 36.23
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most of them were not previously detected by cytogenetic
studies (see Table 4 and Supplementary Data). Most subjects
had terminal deletions (65/70, 92.85%), and five individuals
carried interstitial deletions (represented in Supplementary
Figure 2B). Among the terminal deletions, 16 of them (22.85%),
had an additional terminal duplication in other chromosome,
which could result from a possible translocation (de novo or
inherited). Cytogenetic analysis of the parents allowed us to
establish whether the rearrangements were familiar (6 cases)
or de novo (10 cases). In one case, the 5p deletion was
inherited from a maternal mosaicism (6.5% of cells in blood)
unknown until the moment of diagnosis of the child. We
found patients with additional terminal deletions in other
chromosomes (two cases, 2.85%) and additional rearrangements
at chromosome-5 nearby the deletions (seven cases, 10%).




The great heterogeneity observed in patients with this syndrome
together with the high number of other significant genomic
rearrangements (besides the 5p deletions) raised the question
whether the presence of these additional rearrangements may
modulate functionally the clinical features in this syndrome
and to explain the high intra-cohort variability. We proposed a
graduation of the individual global assessment of functionality
(GFAP), constructing one continuous variable, based on the
frequency of the different “nuclear” clinical items (i to v, see
section “Materials and Methods”), and our clinical experience
in the syndrome.
To verify this GFAP scale construction, a statistical
combined analysis of Kaiser–Meyer–Olkin’s, Bartlett’s, and
principal component analysis (PCA) test were performed
to detect the best way of association between these grouped
clinical features. Indeed, the first principal component (PCA
1) from PCA weighed the major score of the variance,
supporting that PCA1 can be written as a weighted average
of the five original variables. Finally, Pearson correlation
analysis showed that PCA1 and the item GFAP are very
significantly correlated (Pearson correlation value = 0.846;
P = 0.001). The dispersion plot shows the strong linear
correlation among them and therefore justifies GFAP as a valid
construct (Figure 3).
Table 5 shows the median and mean ± SD values for GFAP
and its intermediates “functional” components for the whole
cohort, and both subpopulations: simple deletions (47 cases) and
patients with deletions and additional rearrangements (mainly
duplications, 23 cases).
Comparative Analysis
Among Subpopulations With and Without Additional
Rearrangements
A chi-square test was performed to compare categoric
variables in both groups: simple (isolated) 5p deletions and
those including 5p deletions and additional rearrangements
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Size (Mb) Chromosome Coordinates start Coordinates end Size (Mb)
1 5p15.33-p15.1 25328 17981563 17.98 Xp22.33 169805 2123990 2.12
2 5p15.33-p14.3 25328 22446214 22.44 10q25.3-q26.3 115402474 135434319 20.08
3 5p15.33-p15.2 25328 12995938 12.99
4 5p15.33-p14.1 25328 28779357 28.77
5 5p15.33-p14.3 25328 22956970 22.95
6 5p15.33-p15.31 25328 9438756 9.43 Xq28 154933691 155236712 3.72
7 5p15.33-p13.2 25328 34602269 34.60
5p13.2** 34602654 36816661 2.21
8 5p15.33-p13.3 25328 31853346 31.85
9 5p15.33-p13.2 25328 35015297 35.02
10 5p15.33-p14.1 25328 25290077 25.30
11* 5p15.32-p15.1 4928318 15418957 10.49
12 5p15.33-p14.2 25328 24430251 24.43
13 5p15.33-p14.1 25328 28783716 28.78
14 5p15.33-p15.32 25328 4938756 4.94
15 5p15.33-p13.3 25328 34986724 34.98
16 5p15.33-p15.1 25328 17665529 17.60 12p11.21 32875287 33056330 0.18
17 5p15.33-p14.1 25328 25027051 25.02
18 5p15.33-p15.1 25328 15913112 15.91 8p23.3p-23.1 176617 11860710 11.86
19 5p15.33-p14.1 25328 25396006 25.40 5p14.1 25409917 28435493 3.025
20 5p15.33-p15.1 25328 15808138 15.81
21 5p15.33-p15.2 25328 12978580 12.98 10q-26.11-q26.3 121556072 135425341 13.87
22 5p15.33-p15.2 25328 11037420 11.037
23 5p15.33-p15-32 25328 4356789 4.35 5p15.33-p15.32 4355708 4969019 0.60
5p15.31 6325532 6642356 0.30
24 5p15.33-p14.1 25328 27108052 27.10
25 5p15.33-p14.3 25328 21872896 21.88 9p24.3-p22.1 46587 19713500 19.7
26 5p15.33-p14.3 25328 22658970 22.65 8p23.2-p11.23 2061877 34908297 34.94
27 5p15.33-p15.2 25328 14360436 14.36
28 5p15.33-p13.3 25328 29485091 29.48
29 5p15.33-p13.3 25328 29292854 29.29 1p13.1-p12 117594464 117989275 0.38
30 5p15.33-p13.3 25328 32130401 32.13
31 5p15.33-p14.1 25328 27708038 27.71 18p11.32 13034 2656248 2.65
32 5p15.33-p14.1 25328 28147535 28.15
33 5p15.33-p14.1 25328 26622073 26.62 5p13.3-p13.2 26695268 34019038 7.67
34 5p15.33-p14.1 25328 28796749 28.79
35* 5p15.33-p15.1 560000 17509888 16.95
36 5p15.33-p14.1 25328 25821865 25.82
37 5p15.33-p14.3 25328 21504581 21.50 8p23.3-p23.2 164984 752709 0.75
22q11.21 25661725 25914593 0.25
38 5p15.33-p15.32 25328 4610206 4.61 5q35.1 169708691 169893751 0.18
5q35.1-q35.3 171656863 180693344 9.03
39 5p15.33-p15.1 25328 15922302 15.92
40 5p15.33-p14.2 25328 24438467 24.43
41 5p15.33-p14.1 25328 25135494 25.13 11q22.1 100578089 100870339 0.29
42 5p15.33-p15.1 25328 15022112 15.02 9p24.3-p21.3 162931 23232287 23.24
43 5p15.33-p14.1 25328 28464893 28.46 18p11.32-p11.31 141896 6785383 6.78
44 5p15.33-p14.2 25328 24247673 24.24
45 5p15.33-p15.1 25328 17704161 17.70 5p14.3 19970119 20370847 0.4
(Continued)
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Size (Mb) Chromosome Coordinates start Coordinates end Size (Mb)
46 5p15.33-p13.2 25328 28929082 28.92 5p13.3-p13.2 28968268 34497445 5.53
47 5p15.33-p15.1 25328 16410000 16.41
48 5p15.33-p13.3 25328 31131409 31.13
49 5p15.33-p15.2 25328 14270500 14.27
50 5p15.33-p15.2 25328 14061184 14.06 7p22.3-p11.3 44935- 11857504 11.86
51 5p15.33-p15.1 25328 16661282 16.67
52 5p15.33 25328 618586 0.62 2q36.3-2q27.3 22990625 243048760 13.14
2q36.3 228782976- 229669531 0.89
53 5p15.33-p15.31 25328 7125022 7.12
54 5p15.33-p15.31 25328 7125022 7.12
55 5p15.33-p13.3 25328 30210500 30.21
56 5p15.33-p15.32 25328 4610206 4.61 2p15.3-p25.2 14238 4698068 4.68
57* 5p15.1-p13.3 17509888 32677299 15.17
58 5p15.33-p13.3 25328 34119847 34.11 Xp22.31 6447911- 8135053
59 5p15.33-p13.3 25328 30480030 30.48
60 NA NA NA NA
61 5p15.33-p15.1 25328 15652433 15.65 11p15.5-p15.4 75328- 10525251 10.5
62 NA NA NA NA
63 5p15.33-p15.13.3 25328 30445734 30.44
64 5p15.33-p15.32 25328 4610206 4.61 2p15.3-p25.2 14238 4698068 4.68
65 5p15.33-p15.32 25328 4610206 4.61 2p15.3-p25.2 14238 4698068 4.68
66* 5p142-p13.2 23383424- 36609355 13.22
67 5p15.33-p15.31 25328 7125022 7.12
68** 5p15.33-p13.3 25328 29292854 29.29
69 5p15.33-p15.32 25328 5014883 5.01
70* 5p15.2-p13.3 9860050 33760050 23.09
*Means, interstitial cases. **Means, mosaics.
(mainly duplications). Interestingly, the presence of additional
rearrangements may exert significant differences on prenatal and
postnatal growth delay findings, cardiac anomalies, and speech
abilities in the expressive language (Table 6, P ≤ 0.05, at CI 95%).
Remarkably, other findings became significant at CI of 90%, such
as cleft lip/palate, renal anomalies, autistic spectrum disorders
(ASD), or breathing difficulties (Table 6).
Ward cluster analysis allowed us to compare the
frequencies of these variables in both subpopulations.
We denote that better figures (low percentages) were
more represented in the simple 5p deletion group, but
with motor items, slightly better than in the group with
additional rearrangements (Table 5 and Supplementary
Data). Although the simple deletion group had a higher size
of 5p deletions on average (see Supplementary Table 5),
no statistical significant differences could be observed
between the two different subpopulations (Student t-test,
see Figure 4).
We also performed an association analysis among categoric
variables in both subpopulations by Kendall’s tau_b analysis
(expanded analysis for the whole cohort and subgroups is
presented in Supplementary Table 3). Interestingly, some of
the observed correlations in the simple 5p deletion group
disappeared in the group with additional rearrangements
(Figure 5). A more specific example for three of these categoric
variables is presented in Supplementary Figure 3.
Genotype–Phenotype Correlations
We made Ward’s hierarchical cluster analysis using the item
“size of deletion” as unique variable, in order to verify how
individuals (initially, from the whole cohort) group according
to their deletion size. At the end, individuals were grouped
in four clusters (the number was established by BIC and AIC
algorithms), as follows: 4.97 ± 1.83 Mb, 14.64 ± 2.31 Mb,
24.01 ± 1.38 Mb, and 29.95 ± 2.93 Mb (Figures 6A,B). ANOVA
analysis discarded a significant correlation between the size
of the deletion and the functional item, GFAP, or any of its
intermediates (P = 0.07 at CI 95%, data not shown). However,
ANOVA analysis for continuous variables or by chi-square
test for categoric variables shows the existence of significant
differences between clusters in a few variables, mostly related
to perinatal parameters, some dysmorphic features, behavior,
and cognitive features (Figure 6C). Further, Bonferroni’s and
z-tests for previous significant variables revealed that cluster 3
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FIGURE 3 | Validation of a GFAP construct by PCA (principal component analysis) statistical approach. Pearson correlation value = 0.846; P = 0.001.
TABLE 5 | Mean (±SD) and median of GFAP (Global Functional Assessment of the Patient) and its intermediates (items “i” to “v”) from the whole cohort and
subpopulations of 5p- individuals.
Whole cohort Single 5p deletions 5p deletions plus additional
rearrangements
“Functional” variable Median Mean ± SD Median Mean ± SD Median Mean ± SD
GFAP 387.60 388.40 ± 100.00 361.50 362.89 ± 98.50 404.00 398.70 ± 92.00
(i) Developmental delay items corrected by age 251.00 244.60 ± 66.40 228.50 233.80 ± 59.50 249.00 229.10 ± 73.00
(ii) Behavioral alteration items 7.50 13.40 ± 15.40 7.00 10.80 ± 12.10 7.00 15.00 ± 19.60
(iii) Dysmorphic items 24.00 21.10 ± 11.60 24.00 20.30 ± 11.80 24.00 19.00 ± 0.60
(iv) Communication skills 48.00 54.10 ± 25.80 45.00 50.50 ± 25.80 60.00 58.20 ± 23.80
(v) Comorbidity items 47.00 55.20 ± 47.00 47.00 48.80 ± 38.80 67.00 61.50 ± 37.50
Values are expressed in arbitrary units. Higher values are associated with a worse functional prognosis.
TABLE 6 | Comparison between subpopulations in 5p- individuals, regarding categorical variables taken.
Chi-square test
Simple 5p dels N = 47 5p dels + addt rearrangement N = 23 Value df Sig. asymptotic (bilateral)
IUGR 14 13 1.701 1 0.019*
Postnatal growth failure 16 17 3.716 1 0.036*
Cardiac anomalies 10 14 6.020 1 0.014*
Short understandable sentences 14 2 5.299 1 0.021*
Cleft lip-palate anomalies 2 5 3.543 1 0.060$
Renal anomalies 3 6 3.441 1 0.064$
ASD 3 6 3.441 1 0.064$
Prominent superciliary arches 5 0 3.381 1 0.066$
Breath problems 13 14 3.272 1 0.070$
No words at all 10 11 3.187 1 0.074$
Interact with the environment 34 16 3.189 1 0.074$
* means significant p-value ≤ 0.05; $ means possible tendency, significant at CI 90% (data not shown). N is the number of patients evaluated.
Frontiers in Genetics | www.frontiersin.org 11 July 2021 | Volume 12 | Article 645595
fgene-12-645595 July 30, 2021 Time: 12:21 # 12
Nevado et al. 5p Minus Syndrome in Spanish Individuals
FIGURE 4 | Schematic representation of the comparison between subpopulations in 5p- individuals (5p deletions vs. 5p deletion plus additional rearrangements) in
the “functional” constructed GFAP (Global functional Assessment of the Patient) and its intermediates (developmental delay items corrected by age, behavioral items,
dysmorphic items, communication skills, and comorbidity items). A Student t-test was performed.
(size 24.01 ± 1.38 Mb; 5p15.1–p14.1) is the most represented
among the cluster pairs with significant differences among
them (Figure 6C).
When Ward’s clusters were dissected by item frequencies
(in percentages), higher percentages (normally associated with
a worse prognostic) seemed to be mapped, in cluster 3
too (Table 6 and Supplementary Data). However, expressive
language (followed by item, the ability to make short sentences)
or the ability to write or read was associated preferentially
with clusters 1 and 2 (11/16 individuals, 69%). Figure 7 shows
how the four clusters integrate into suggested functional areas
of chromosome-5p of several previously published data. We
observed some relevant mapping findings such as the item speech
delay, which was mapped at the beginning of the telomere.
We further analyzed these possible differences among clusters
(by size of deletion) in the two subpopulations of 5p- Sd
individuals (simple, isolated 5p deletions vs. 5p deletions plus
additional rearrangements), using the same statistical approach
presented above. Supplementary Figure 4A showed a similar
result for simple deletions. We also found intra-cluster significant
differences for some variables, with cluster 3 again as the most
representative cluster for significant differences in the pair of
cluster comparisons (Figure 4A and Supplementary Data).
Remarkably, one of these variables that showed differences
among clusters was GFAP. For analysis of the group with
additional rearrangements, we generated only two clusters for
comparison (due to the number of individuals) but also denoted
significant differences between clusters “A” and “B” (now, cluster
“A” aggregates clusters 1 and 2 and “B” clusters 3 and 4,
Supplementary Figure 4B).
Finally, Pearson correlation analysis established that the size of
the deletion inversely correlated with some neonatal parameters,
such as weight or OFC (P ≤ 0.001), and almost with birth length
(P = 0.061). However, the most significant genotype/phenotype
correlation was observed between size of the deletions and gender
(males, 15.79 ± 8.79 vs. females, 22.38 ± 8.84. Student t-test,
P = 0.004).
Male vs. Female Comparative Analysis
A chi-square test was performed for the whole cohort and two
of the subpopulations. Table 7i shows the statistic significant
differences between males and females in the whole cohort.
These differences were mostly related to growth delay (prenatal
and postnatal), dysmorphic features, some spinal comorbidities,
and behavioral and cognitive aspects. In addition, Ward cluster
analysis between males and females showed the worst frequencies
(in percentages) in females (Table 7 and Supplementary Data).
As we expected, neonatal data at birth showed also significant
differences among gender and weight and OFC (P ≤ 0.01
and P ≤ 0.05, respectively, Student t-test) or with length at
birth (P = 0.074, Student t-test). Most remarkably, there were
also significant differences at the functional GFAP (P = 0.05,
Student t-test). These differences showed higher values of
frequencies (mainly, a worse prognosis) in females. Similarly, we
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FIGURE 5 | Schematic representation of the comparison between subpopulations in 5p- individuals (5p deletions vs. 5p deletion plus additional rearrangements) in
categoric variables using Kendall’s tau_b statistical analysis. Very significant differences (P ≤ 0.01) were denoted in bold. Circles denote significant differences among
variables observed in the 5p deletion group and absent in the 5p deletion + additional rearrangement group.
compared male vs. female significant differences for all categoric
variables (in both isolated deletions and deletions + additional
rearrangements) (Tables 7ii,iii). Significant correlations were
found among gender, independently of the group. The only
significant difference in common was intrauterine growth
retardation (IUGR). Again, the most remarkable finding with
significant differences in the simple 5p deletion group was GFAP
(Table 7ii), but not in the group with additional rearrangements
(Table 7iii). On the other hand, patients with additional
rearrangements also showed significant differences in neonatal
data, such as weight or OFC at birth, again as the whole cohort,
showing better numbers in males than in females. Expanded
Student t-test analysis is shown in Supplementary Table 8.
DISCUSSION
In this work, we describe the largest cohort of Spanish patients
with 5p- Sd and one of the largest series of these patients
so far, characterized by means of CMA and other genetic
approaches, such as cytogenetics, MLPA, and FISH. Although its
prevalence is still unknown, it was estimated around 1:15,000–
50,000 (Niebuhr, 1978; Higurashi et al., 1990; Cerruti Mainardi
et al., 2006). Our data showed that 5p- individuals may have
a high clinical variability that is accompanied also by a high
genetic heterogeneity. In fact, individuals with 5p- syndrome
do not always carry a single rearrangement. In our cohort,
around 39% of the individuals presented an additional clinically
significant genomic rearrangement, mainly a duplication in
other chromosomes. In other cases, additional deletions and
duplications can be observed nearby the main 5p deletion (seven
cases), probably as a result of a complex rearrangement, as it
has been previously suggested (Gu et al., 2013). These additional
rearrangements raised the question of whether additional
genomic rearrangements may have a role in the syndrome, and
thus, it may explain part of its variability, or if individuals
with additional rearrangements should be considered as having
5p minus syndrome.
We described and compared our cohort with other previously
reported series in terms of clinical features. Some limitations of
this study come from information taken from the questionnaires
filled up by parents or caregivers. This could explain part of these
differences among subjects. We strongly recommend systematic
codification of clinical features using the HPO system.
We think that frequency-weighed HPO terms grouped
in five main nuclear features of the syndrome will help
clinicians to describe 5p- Sd patients (Table 3). We built
a quotation scale called GFAP (see sections “Materials and
Methods” and “Results”). We compared this “functional”
GFAP and its intermediate components in order to establish
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FIGURE 6 | (A) Ward’s hierarchical cluster of the whole cohort by size of the deletions. BIC and AIC determined to be grouped by four clusters. (B) Plot segregation
ordered by deletion size in Mb. Every cluster showed the GFAP value. (C) ANOVA analysis for continuous variables or by chi-square test for categoric variables was
performed to establish the existence of significant differences between clusters. Further, Bonferroni’s test and z-test for previous significant variables revealed cluster
pairs with significant differences among them.
putative significant differences between both subpopulations:
simple, isolated 5p deletions and 5p deletions with additional
rearrangements. However, no statistical significant differences
(Student t-test) could be observed between the two different
subpopulations for the GFAP variable, although several
significant differences could be denoted among other clinical
features. The most relevant were cardiac anomalies and
speech delay and the presence of additional rearrangements.
Regarding behavioral aspects, there were significant differences
among subpopulations in sleeping problems, stereotypical
or aggressive behavior, and number of behavioral problems,
being more common in the group with an additional genomic
rearrangement. Thus, the latter showed better numbers in some
cognitive items than simple 5p deletions. Altogether and based
on statistic analysis, the presence of additional duplications did
not have any significant representation over the whole phenotype
of the 5p- patient, but it might have specific contributions for
some clinical findings such as growth delay (either prenatal or
postnatal) as well as cardiac anomalies.
Genotype–Phenotype Correlations
Some authors have previously stated that the severity of the
phenotype and the cognitive delay of 5p- Sd were associated with
an increased size of the deletion at chromosome 5p (Wilkins
et al., 1983; Cornish et al., 1999; Cerruti Mainardi et al., 2001).
However, this fact was not confirmed by others (Marinescu
et al., 1999; Espirito Santo et al., 2016). Thus, this aspect is
still controversial. We used our “functional” construct GFAP to
validate this hypothesis. Our data supported these genotype–
phenotype correlations only in simple deletions. Since there is
a scant number of publications in this syndrome incorporating
microarray data, it cannot be discussed whether this fact has
occurred in other cohorts. For instance, Cerruti Mainardi et al.
(2006) analyzed genotype–phenotype correlations but only in
patients with isolated 5p terminal deletions (151/185 cases).
Furthermore, if a part of the huge phenotypic variability
observed among 5p- individuals was not related to the size of
the deletion, the other possibility may be established by the
location of the deletion, since it is a chromosomal region with
an important gene content. Our data supported that specific
regions at chromosome 5p may have more significant roles in
the syndrome than others. Our analysis of clusters (by size
of the deletion) showed that cluster 3 was the most relevant
among the cluster pairs with statistically significant differences,
both in the whole cohort and subpopulation groups. In fact,
the worst frequencies of most categorical items, as well as
GFAP and its intermediates in cluster 3, seem to support this
observation. Cluster 3 mapped at 18–25 Mb from the telomere
(chromosomal bands 5p15.1–5p14.1). Among the genes mapping
in this area were the cadherin (CDH) cluster, including CDH10,
CDH9, CDH12, CDH18, and CDH6, strongly associated with
this syndrome. This CDH cluster has been described to be
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FIGURE 7 | Integrative map for clusters shown in Figure 6. Comparisons with previously reported critical regions for phenotype sings at 5p minus syndrome
(references refer to clinical symptoms reported in individual families with interstitial deletions in different reported works). Circles represent the areas mapped for the
different clusters obtained in Ward’s analysis. Major findings observed in our study are in italic text. Chromosome bands are reported according to ISCN. ID,
intellectual disability.
conditionally haploinsufficient and depend on other genetic
or environmental factors leading to an abnormal phenotype.
This is an interesting fact and could also explain part of
the variability observed in 5p-Sd. Other genes in this region
are FBXL7, MARCH11, FAM134B, MYO10, DROSHA, PDZD2,
GOLPH3, MTMR12, ZFR, SUB1, NPR3, and TARS. All genes
have a significant level of haploinsufficiency (see Supplementary
Table 9). However, we cannot rule out a role for other genes such
as CTNND2, TERT, and MED10, commonly deleted in 5p- Sd
and associated with neuronal development/function and cellular
death. The smallest region of overlap patients with interstitial
deletions pointed out to two potential regions, one mapping at
these genes and the other in the cadherin cluster. Additional
interstitial cases and functional assays are needed to unreveal the
role of all these genes.
Speech skills (evaluated only in patients aged >3 years)
yielded that the potentially affected region is near to the telomere
(5p15.33–5p15.31) supporting previous findings (Church et al.,
1995; Zhang et al., 2005). High frequencies for most of the
behavioral findings seemed to be associated with clusters 3 and 4
in our Ward’s cluster analysis and supported previous studies for
its hypothetical mapping (Barber et al., 2011). On the other hand,
our data also showed some discrepancies with previous studies. In
our study, high-pitched cry seemed to map at p14.3–p13.2 bands
versus bands p15.33–p15.31 (Overhauser et al., 1994; Gersh et al.,
1995; Cerruti Mainardi et al., 2001), p15.31 (Zhang et al., 2005),
p15.31–p15.2 (Church et al., 1995), or p15.2 (Wu et al., 2005) in
other previous reports.
Gender as a Differentiating Factor:
Correlations Depending on Gender
A suspicion of putative cognitive and “functional” differences
between males and females patients has been constantly
suggested to us by parents, caregivers, and several clinical
specialists. This is the first report showing “functional”
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TABLE 7 | Comparison between male and female 5p- individuals, regarding categorical and continuous variables taken by means of the chi-square and Student t-test,
respectively, in (i) the whole cohort, (ii) simple 5p deletions, and (iii) 5p deletions plus additional rearrangements.
(i) The whole cohort
Chi-square
Male Female Value df Sig. asymptotic (bilateral)
IUGR 3 27 9.42 1 0.002**
Postnatal growth failure 7 26 3.838 1 0.050*
Round face 6 26 5.318 1 0.021*
Enlarged face 12 11 5.794 1 0.016*
Neck anomalies 1 12 4.583 1 0.032*
Alterations of the fingers or toes 6 25 4.598 1 0.032*
Spinal anomalies 2 16 5.194 1 0.023*
Scoliosis 4 21 5.009 1 0.035*
Severe ID 5 26 7.058 1 0.008**
Aggressive and self-mutilation 4 23 6.486 1 0.011*
Sleeping problems 8 30 5.255 1 0.022*
Can read/write 7 5 3.911 1 0.048*
Short understandable sentences 9 7 4.701 1 0.030*
Mild ID 5 3 3.598 1 0.058$
Student t
Male Female Sig.
Weight at birth (g) 2925.91 689.24 2447.28 621.33 0.006**
OFC at birth (cm) 33.17 2.27 31.74 2.37 0.021*
GFAP 358.87 73.39 402.94 108.60 0.050*
Height at birth (cm) 47.11 3.79 45.31 3.86 0.074$
(ii) Simple 5p deletions
Chi-square
Male Female Value df Sig. asymptotic (bilateral)
IUGR 2 12 4.669 1 0.0031**
Faillure to thrive 3 13 3.716 1 0.054
Larynx and epiglottis alterations 1 10 5.002 1 0.025*
Severe ID 3 14 4.605 1 0.032*
Aggressive and self-mutilation 3 14 4.605 1 0.032*
Sleeping problems 4 16 4.740 1 0.029*
Spinal anomalies 1 8 3.318 1 0.069$
Student t
Male Female Sig.
GFAP 336.31 61.36 396.37 123.10 0.040*
Behavioral item, as component of GFAP 7.73 11.72 22.63 13.77 0.063$
(iii) 5p deletions + additional rearrangements
Chi-square
Male Female Value df Sig. asymptotic (bilateral)
IUGR 1 12 4.34 1 0.037*
Round face 1 12 1.73 1 0.037*
Enlarged face 6 4 9.60 1 0.002**
(Continued)
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TABLE 7 | Continued
(iii) 5p deletions + additional rearrangements
Chi-square
Male Female Value df Sig. asymptotic (bilateral)
Ophthalmological anomalies 1 12 4.34 1 0.037*
Short understandable sentences 2 0 5.59 1 0.018*
Auditive problems 5 6 3.68 1 0.055$
Student t
Male Female Sig.
Weight at birth (g) 3314.29 686.24 2469.60 586.85 0.004**
OFC at birth (cm) 34.79 1.55 31.44 2.11 0.001**
Size of the deletions 10.25 6.81 21.60 8.69 0.004**
* means significant p-value ≤ 0.05. ** means significant p-value ≤ 0.01. $ means possible tendency, significant at CI 90% (data not shown).
differences between males and females in 5p- Sd individuals.
We found that some of the clinical features analyzed showed
statistically significant differences among males and females,
for instance in the GFAP variable. Thus, we denoted worse
functional scores and higher deletion sizes in females
than in males using Ward’s cluster analysis. Additional
efforts with systematic cognitive–behavioral evaluations of
the patients must be performed in order to assign more
precise differences.
The reason why the ratio female–male is 2:1 is still unknown.
One of the most relevant differences between genders is the
mean value for size of the deletions. Interestingly, Ward’s cluster
analysis allowed us to observe how the female/male ratio was
modulated by the different sizes of the deletions in the clusters
(Tables 5, 7 and Supplementary Data). The number of males in
these clusters decreased drastically when the size of the deletion
increased over 15 Mb. This fact may suggest a different, possibly
lethal, effect of deletions over 15 Mb in males and might explain
the differences among the female/male ratio in this syndrome.
In fact, miscarriages are frequent in this syndrome. This is
not an unusual effect because other genes at 5p13.1, such as
RICTOR and DAB2, have been suggested to be haplolethals
(Peng et al., 2020) and may explain how deletions do not
expand in size, more than 39 Mb from the telomere. However,
we cannot rule out any other additional genetic or epigenetic
effect in males, affecting chromosomal bands 5p15.1–p13.2. In
fact, an aberrant DNA methylation in Cri du chat syndrome
related to development conditions has been already suggested
(Naumonova et al., 2018).
CONCLUSION
Summing up, we here report a large series of patients with
5p minus syndrome emphasizing some phenotype–genotype
correlations. Remarkably, we found statistically significant
“functional” differences among males and females. We also
dissected subpopulations in 5p- Sd based on the presence/absence
of clinical significant additional rearrangements, besides losses at
the 5p arm. The presence of these additional rearrangements may
have a role modulating part of the phenotype in the syndrome.
Finally, we recommend combining typical karyotyping with
CMA as the definitive method for a precise diagnosis of 5p-
Sd, in order to provide a more accurate genetic counseling
for these families.
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